US stocks unusual movement | Reached an agreement to sell experimental anti-cancer assets with Gilead Sciences (GILD.US) Repare Therapeutics (RPTX.US) rose nearly 20% before the market opened.

According to the Securities Times APP, on Wednesday, the Canadian biotech company Repare Therapeutics (RPTX.US) surged by about 20% in pre-market trading. Earlier, the company announced that it had reached an agreement with Gilead Sciences (GILD.US) to acquire its experimental cancer therapy RP-3467, with a total transaction value of up to $30 million.